These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18999912)

  • 1. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic amniocentesis in women 20-34 years old: associated risks.
    Antsaklis A; Papantoniou N; Xygakis A; Mesogitis S; Tzortzis E; Michalas S
    Prenat Diagn; 2000 Mar; 20(3):247-50. PubMed ID: 10719331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal cytogenetic diagnosis: first 1,000 successful cases.
    Hsu LY; Kaffe S; Yahr F; Serotkin A; Giordano F; Godmilow L; Kim HJ; David K; Kerenyi T; Hirschhorn K
    Am J Med Genet; 1978; 2(4):365-83. PubMed ID: 162527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers.
    Muller F; Thibaud D; Poloce F; Gelineau MC; Bernard M; Brochet C; Millet C; Réal JY; Dommergues M
    Prenat Diagn; 2002 Nov; 22(11):1036-9. PubMed ID: 12424771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases.
    Mazza V; Pati M; Bertucci E; Re C; Ranzi A; Percesepe A; Forabosco A; Volpe A
    Prenat Diagn; 2007 Feb; 27(2):180-3. PubMed ID: 17238217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.
    Odibo AO; Gray DL; Dicke JM; Stamilio DM; Macones GA; Crane JP
    Obstet Gynecol; 2008 Mar; 111(3):589-95. PubMed ID: 18310360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis].
    Miny P; Tercanli S; Gänshirt D; Holzgreve W
    Ther Umsch; 1995 Dec; 52(12):792-800. PubMed ID: 8539649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.